To investigate this variable CYSLTR2 expression, we further analysed the 77 primary melanomas from the TCGA cohort and extended the analysis with the eight primary and three metastatic melanomas studied using single cell RNA sequencing as described by Durante et al. [13, 14]. The gene discussed is CYSLTR2; the disease is metastatic melanoma.